Back

Spatial neglect therapy with the augmented reality app 'Negami' for active exploration training; A randomized controlled trial

Stammler, B.; Flammer, K.; Schuster, T.; Lambert, M.; Neumann, O.; Lux, M.; Matuz, T.; Karnath, H.-O.

2023-03-29 rehabilitation medicine and physical therapy
10.1101/2023.03.26.23287770 medRxiv
Show abstract

BackgroundA widely applied and effective rehabilitation method in stroke patients suffering from spatial neglect is the visual exploration training. Patients improve their ipsilesional bias of attention and orientation by training of exploration movements and search strategies towards the contralesional side of space. Here we investigate the effectiveness of the augmented reality (AR)-based app "Negami" for the treatment of spatial neglect in a randomized control trial. Negami combines a visual exploration training with active, contralesionally oriented rotation of eyes, head, and trunk. MethodsTwenty patients with spatial neglect were randomly assigned to the experimental Negami group or to a group receiving standard neglect therapy. Over a period of two weeks, both groups received five training sessions per week (a 25 minutes). Neglect behavior was assessed weekly over a five-week period, with the Negami therapy group receiving a second follow-up assessment at one-to-two-month intervals after completion of training. ResultsBoth groups improved significantly. While the Negami therapy group improved in four of five neglect tests used, the standard therapy group improved in only one of these tests. We observed significantly better improvement in the Negami group already after the first week of training. This difference was also significant after the end of the training as well as one week after the end of training and remained stable one to two months after the end of treatment. ConclusionNegami can be used as an effective alternative or addition to current standard neglect therapy, and may even be superior to it. Trial Registration at "OSF Preregistration", Registration DOI: https://doi.org/10.17605/OSF.IO/H6XN5 and at WHO approved public trial registry "German Clinical Trials Register", DRKS-ID: DRKS00031446

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.